The aim of this study was to evaluate whether salt-sensitivity in essential hypertension produces a significant comparative difference in diastolic function and ventricular mass when compared with sodium-resistance. Recent epidemiological data have demonstrated a positive correlation between sodium intake and arterial pressure. Furthermore, a positive correlation has been detected between sodium intake and left ventricular hypertrophy (LVH) independently of arterial pressure.
Introduction
Over recent years interest has increased in the nonpharmacological treatment of arterial hypertension.
Appropriate changes in health and dietary habits seem to be useful in the prevention and treatment of arterial hypertension. It is widely agreed that those factors which lead to the best results are: alcohol consumption reduction, weight loss, taking calcium and potassium supplements and sodium intake reduction. [1] [2] [3] [4] The relationship between sodium intake and The left ventricular mass measurement showed higher values in the SS group although this did not reach statistical significance (118.4 ؎ 4.4 vs 112.0 ؎ 4.2 gr/mq, P ‫؍‬ NS). Both interventricular septal and posterior wall thickness did not demonstrate significant differences between the two groups. The salt-sensitive group showed impaired left ventricular diastolic function; in particular, the first diastolic peak representing the early maximum of diastolic filling velocity (E) was lower in SS subjects than in SR subjects (71.6 ؎ 2.9 vs 83.1 ؎ 3.3 cm/sec, P Ͻ 0.02). No significant difference was detected in the second peak representing the atrial maximum of filling velocity (A) (69.0 ؎ 2.3 vs 66.0 ؎ 2.0 cm/sec, P ‫؍‬ NS). As a consequence the E/A ratio was significantly different (0.73 ؎ 0.2 in the SR vs 1.2 ؎ 0.04 in the SS group, P Ͻ 0.05). Moreover, the peak E integral was lower in SS than in SR subjects (8.7 ؎ 0.6 vs 11.2 ؎ 0.5 cm, P Ͻ 0.005; no difference for the peak A integral (6.0 ؎ 0.3 vs 5.7 ؎ 0.4 cm, P ‫؍‬ NS). The E peak deceleration time was significantly reduced in the SS group (400.3 ؎ 13.5 vs 500.9 ؎ 12.8 cm/sec, P Ͻ 0.001). No significant difference was found for the isovolumetric relaxation time (IVRT) (95.7 ؎ 4.3 vs 92.2 ؎ 4.0, P ‫؍‬ NS). Our data show an impaired diastolic function expressed by a reduced early diastolic filling velocity (peak E) and a significantly abnormal E/A ratio in SS in comparison with SR subjects. Therefore abnormalities in diastolic function are detectable earlier in SS hypertensive subjects than in SR irrespective of actual MAP.
hypertension is well known but, despite the fact that a vast number of studies have been devoted to the subject, the importance of salt in the aetiology and treatment of arterial hypertension is still unclear. [5] [6] [7] The heterogeneity of the pressure responses has enabled two types of hypertensive patients to be identified: sodium-sensitive (SS) and sodium-resistant (SR). 8 Sodium sensitivity is more frequently found among the black races, in the elderly and in obese subjects. 9 It would also appear to be favoured by potassium depletion and low calcium intake. 3, 4 Endogenous vasoconstrictive factors such as sympathetic nervous system, 7,10 also come into play in SS patients. Moreover, baseline concentrations of renin are generally lower and the natriuretic response to an increased sodium intake is less pronounced in SS than SR subjects. 7, 11 It has recently been suggested that insulin could be a susceptibility factor as regards dietary sodium intake. In fact SS patients are often insulin-resistant. 12 It is also known that arterial hypertension, in generating an increase in afterload, is a factor which can lead to the development of left ventricular hypertrophy (LVH). 13 This adaptation mechanism could be considered to be initially favourable. [13] [14] [15] However, recent epidemiological studies demonstrate that LVH, even in subjects not affected by arterial hypertension, is an independent risk factor for major cardiovascular events such as myocardial infarction, sudden death and thrombo-embolic stroke. 16, 17 On average, 40% of hypertensive subjects present with LVH. Although there is an undeniable relationship between afterload and LVH, it is not always possible to find a direct correlation between the existence of high blood pressure values and ventricular mass. 18 The diastolic function is also altered in borderline hypertensive subjects, as is the early fraction of ventricular filling, which tends to be lower. 19 A fairly large percentage of essential hypertensive subjects show early changes in diastolic ventricular filling, assessable through Doppler echocardiography. 20 In addition to haemodynamic mechanisms, other factors may underlie the development of LVH in hypertension. These include the renin-angiotensin system, 21, 22 the sympathetic nervous system, 23 genetic factors, 24 obesity 25 and sodium intake. Recent clinical trials and experimental investigations have demonstrated that there is a positive correlation between sodium intake and the degree of LVH, irrespective of arterial pressure levels. 26 In this study we examine two groups of hypertensive subjects, divided on the basis of the sodiumsensitivity or sodium-resistance of their blood pressure. They underwent echocardiographic estimates of left ventricular (LV) mass and diastolic functional parameters.
Patients and methods

Patients
Thirty-one patients (9 female and 22 male) aged between 24 and 57 years, affected by uncomplicated essential arterial hypertension who had never been treated before with any drug, were enrolled in the study. They were known to be affected by hypertension for a mean period of 2.5 Ϯ 0.3 years.
Patients were defined as hypertensive if at least three diastolic blood pressure level readings, measured within the 3-month period leading up to the study, exceeded 95 mm Hg.
Blood chemistry analyses and instrumental tests were performed with a view to excluding secondary hypertension. The patients did not present with any other serious diseases or metabolic alterations such as hyperlipidaemia, diabetes or hyperuricaemia and/or signs of organ damage.
Blood samples were taken from the patients in order to measure plasma renin activity (PRA) and aldosterone (radioimmunoassay method), catecholamines (HPLC), insulin (immuno-enzymatic) and urine samples were taken for the determination of electrolytes.
Echocardiographic study
Echocardiography was performed with ATL APO-GEE 800 equipment with the patients in the left lateral recumbent position and using a dual technique: mono-and bi-dimensional. The evaluation of the ventricular mass was performed using M-MODE parasternally along the long axis. The transmitral Doppler study was performed from the fourchamber apex with the sample volume positioned at the apex of the mitral valve folds. The isovolumetric relaxation time (IVRT) was calculated using the Doppler with the five-chamber apical view, positioning the sample volume between the zone of the left ventricular outflow and the folds of the mitral valve. The IVRT was calculated in milliseconds between the end of the Doppler curve of the flow and the base of the E mitral wave. The operator was unaware of the data concerning sodium sensitivity. The following parameters were assessed: ventricular mass using Penn's formula; 27 A and E wave integral; left atrium diameter, posterior wall, interventricular septum, A and E waves, E/A ratio, E and A peak integral, IVRT and E peak deceleration velocity.
Sodium sensitivity test
The sodium sensitivity test was performed 28 by submitting patients to a diet of 30 mmol of sodium per day with a controlled calorie intake (1700-2000 kcal) in order to keep the patient's weight constant. The test was divided into two periods, each lasting 7 days; during the first week the basic diet was supplemented with 190 mmol Na/day, while in the second week the 30 mmol per day sodium intake was not supplemented.
At the end of both the first and the second period, arterial pressure was monitored using Spacelab 90207 equipment (Redmond, WA, USA). Measurements were taken at 5-min intervals, with the patient in a supine position, for 2 h (from 8 to 10 am), a period which accurately reflects mean pressure values over 24 h as previously documented. 29 At the end of both high and low sodium intake periods, urinary sodium excretion was measured with a view to checking patients' compliance with the dietary regime. If the fall in mean arterial pressure (MAP) between the high and low sodium diet periods was у5% individual patients were defined as SS, while with a fall of Ͻ5% patients were classified as SR. The echocardiographic study was performed and the blood samples were taken at the end of the first period of high sodium intake.
Statistics
Statistical analysis was performed using the linear regression and correlation and 't' test for paired or unpaired data when appropriate. A probability level of 5% or more was considered as statistically sig- 
Results
Of the 31 patients who underwent the sodium sensitivity test, 16 were classified as being sodiumsensitive and 15 as sodium-resistant. Table 1 shows clinical characteristics of subjects submitted to the study. Table 2 shows the blood pressure variations in response to the change in sodium intake in SS and SR groups. Urinary sodium excretion, measured on urine samples taken over a 24-h period on the last day of the high and low sodium diets, was found to be 205 Ϯ 14 and 40 Ϯ 3 mMol/24 h respectively for SS subjects, and 172 Ϯ 9 and 30.5 Ϯ 4 respectively for SR (P ϭ NS). Potassium excretion was essentially the same in SS for low (43 Ϯ 3 mMol/24 h) and high sodium diets (57 Ϯ 5 mMol/24 h) and in SR for low (54 Ϯ 4 mal/24 h) and high sodium intake periods (60 Ϯ 3 mal/24 h). Once the patients had been classified according to sodium sensitivity criteria, it was ) 100.2 ± 2.2 99.8 ± 1.6 § low-sodium diet SS, sodium-sensitive; SR, sodium resistant subjects. Statistical significance; high-sodium diet vs low-sodium diet: *P Ͻ 0.02; †P Ͻ 0.01; ‡P Ͻ 0.001; §not significant. observed that the SS subjects had lower PRA and aldosterone values (0.59 Ϯ 0.1 vs 1.20 Ϯ 0.2 ng/ ml/h, P Ͻ 0.02 and 19.6 Ϯ 2.6 vs 34.1 Ϯ 7.1 ng/dl, P Ͻ 0.05 respectively).
As regards insulinaemia (8.8 Ϯ 1.9 vs 6.9 Ϯ 1.5 uU/ml, P ϭ NS) and catecholamines (noradrenaline 202.3 Ϯ 21.7 vs 180.8 Ϯ 27.1 pg/ml, P ϭ NS; adrenaline 15.0 Ϯ 3.8 vs 15.4 Ϯ 3.3 pg/ml, P ϭ NS), no significant differences were observed in the two groups (Figure 1) .
Differences in the echocardiographic parameters were found in the two groups. Although remaining within normal limits, the left ventricular mass, indexed according to body surface area, tended to be higher in SS subjects than in SR subjects Diastolic function indicators, on the other hand, presented significant differences in the two groups. This applies particularly to the E wave peak, which was markedly lower in SS subjects than in SR patients (71.6 Ϯ 2.9 against 83.1 Ϯ 3.3 cm/sec, P Ͻ 0.02). No significant changes of the A peak were observed: from 69.0 Ϯ 2.3 cm/sec for SS patients to 66.1 Ϯ 2.0 cm/sec for SR patients, P ϭ NS. As a consequence, the E/A ratio was different in the two groups (0.73 Ϯ 0.2 for SS patients vs 1.2 Ϯ 0.04 for SR subjects, P Ͻ 0.05). The E peak integral varied from 8.7 Ϯ 0.6 in SS patients to 11.2 Ϯ 0.5 cm in SR subjects, P Ͻ 0.005 in clear contrast with the A peak integral (6.0 Ϯ 0.3 vs 5.7 Ϯ 0.4 cm, P ϭ NS). The E Figure 1 PRA-Aldosterone system, catecholamines (NA-A) and insulin in sodium-sensitive (SS-white) and sodium resistant (SRblack) subjects. peak deceleration velocity was significantly lower in SS subjects (400.3 Ϯ 13.5 vs 500.9 Ϯ 12.8 cm/sec, P Ͻ 0.001). No significant difference was recorded for the IVRT (95.7 Ϯ 4.3 vs 92.2 Ϯ 4.0, P ϭ NS). The relevant data are displayed in Figure 2 .
Discussion
The hypertensive population is entirely polymorphic, with different characteristics determining different behaviour within the same group of patients.
Sodium-sensitive (SS) hypertensive subjects might, for example, react differently to the complications connected with hypertension, such as LVH, which undoubtedly presents a greater risk of cardiovascular mortality. 18, 19 On the other hand, it has recently been suggested that the tendency to develop ventricular hypertrophy is due to genetic predisposition. 30 Echocardiographic investigations have revealed the existence of morpho-functional alterations prior to the development of LVH, representing the adaptation mechanism used by the heart to cope with chronic pressure overloading on the ventricle.
While age and arterial pressure are determining factors in the genesis of LVH, it is nonetheless important to bear in mind that among subjects of similar age with similar arterial pressure values, some tend to develop LVH earlier than others. Recent studies have demonstrated that sodium intake can contribute to the cardiac changes associated with hypertension. 31, 32 Our study examined two groups of hypertensive subjects with different responses to sodium intake (SS and SR) and with significant variations in some of the echocardiographic parameters, despite there being no visible signs of LVH.
The data indicated an increase, although not of significant dimensions, in left ventricular mass in sodium-sensitive patients. In fact the relationship Figure 2 Diastolic function in sodium-sensitive (SS-white) and sodium resistant (SR-black) subjects.
between sodium intake and ventricular mass index is already well-known in the literature 33 and a positive correlation exists for both normotensive and hypertensive subjects.
In the normotensive subject, this correlation is the result of an increase in telediastolic volume, while in the hypertensive subject it is linked to an increase in the thickness of the left ventricle. Sodium intake, therefore, would appear to be a factor which modulates the growth of cardiac myocytes.
In contrast to the fairly normal cardiac mass indices observed in our study, we detected an initial alteration in the diastolic function, evident from the marked reduction in quick filling speed (expressed by the E peak), in SS patients which differed from that found in SR subjects but with no change in the slow ventricular filling speed (expressed by the A peak). This resulted in a significant variation in the E/A ratio.
While the echocardiographic parameters could still be considered as normal, we could, nonetheless, observe the beginnings of a diastolic function alteration. LVH in the hypertensive subject is characterised by the growth of cardiac myocytes and associated with an increased work load, 34 and an activation of non-myocytic cells (cardiac fibroblasts, vascular smooth muscle, endothelial cells). The diastolic dysfunction, on the other hand, in which we detected active myocardial relaxation, and which takes place prior to the development of LVH, 35 may be attributed to a reduction in ventricular distensibility or to altered ventricular compliance, without any change in the ventricular elastic properties. Several factors may be implicated in these initial alterations of the echocardiographic parameters.
While arterial pressure has been considered in other studies to be an important variable, 36 it cannot be considered to be a determining factor in this particular setting because the SS subjects we exam-ined had a baseline blood pressure essentially identical to that found in SR patients (Table 1) .
The renin-angiotensin-aldosterone system might be involved in growth and myocardial re-shaping. Angiotensin II stimulates hypertrophy by acting directly on the myocytes;
37 aldosterone also appears to have an effect on myocardial fibroblasts, thereby generating an increase in collagen synthesis. 38 However our findings, in agreement with a number of previous reports, 7, 11 show a marked suppression rather than stimulation of the renin-angiotensin-aldosterone system in SS subjects.
The sympathetic nervous system could be one of the pathogenic factors involved. Earlier studies have demonstrated that it may be more active in SS patients at high sodium intake levels. 10 Noradrenaline not only stimulates myocytic hypertrophy by itself 39 but also it contributes in association with other vasoconstrictors such as angiotensin II, vasopressin and endothelin to peripheral vasoconstriction, with increase in left ventricular afterload and subsequent stress on the left ventricular wall and hypertrophy of ventricular muscle. Our data did not reveal any significant differences in circulating catecholamines between the two groups, partly due to the extreme variability of the values among individual subjects.
Sodium intake by itself has been previously indicated as a determining factor of LVH in essential hypertension irrespective of actual blood pressure levels. 40, 41 Our findings, however, provide evidence that SS hypertensive subjects, who showed no difference in both baseline blood pressure and sodium intake in comparison with SR hypertensive patients (Table 1) , had significant echocardiographic abnormalities in diastolic function. This suggests that a combination of the condition of SS and an elevated sodium intake may contribute to explain the early diastolic dysfunction observed in SS patients. In other words, the sensitivity to changes in sodium intake might be a precondition for a sodium-dependent component of LVH of essential hypertension.
In conclusion, our study demonstrates that the sodium-sensitive hypertensive subjects show early modifications in the diastolic function when compared with the sodium-resistant patients, independently of the development of LVH.
